Komipharm is trading at 14,600 KRW as of 1:30 PM on the 16th, up 1.04% from the previous day. This is a decline of 11.52% compared to August 25. Komipharm is known as a manufacturer of veterinary vaccines and disinfectants.
Today, foreigners are tentatively recorded as net buyers of 22,756 shares. Over the past five days, individual investors have net bought 49,359 shares, while foreigners and institutions have net sold 2,893 shares and 62,152 shares, respectively.
On September 8, Komipharm was an issue in the market due to the 'AIFA COVID-19 clinical trial withdrawal news causing weakness.'


※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
